QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

CHE

QT77Chemed Corporation
NYSE·Healthcare·Medical - Care Facilities·USA
Latest market price
436.27
+0.24+0.06%
OverviewShort InterestFilings
CHEQT77Chemed Corporation·NYSE
OverviewShort InterestFilings
436.27+0.06%
TA
Loading chart...
Screen all →
HCA-3.35%$375.17THC-3.32%$172.57DVA-1.27%$207.91SOLV+1.17%$75.43FMS+0.08%$23.59EHC+0.14%$98.03ENSG-1.41%$153.65UHS-0.06%$141.17
Snapshot
Index-P/E22.95EPS (ttm)18.36
Insider Own5.28%
Shs Outstand13.27M
Perf Week3.66%
Market Cap5.79BForward P/E16.21EPS next Y26.91Insider Trans-0.00%Shs Float-Perf Month-0.86%
Enterprise Value6.01BPEG-EPS next Q5.62Inst Own-Short Float-Perf Quarter13.37%
Income252.35MP/S2.28EPS this Y32.64%Inst Trans-Short Ratio-Perf Half Y1.66%
Sales2.54BP/B7.03EPS next Y10.50%ROA16.91%Short Interest-Perf YTD1.97%
Book/sh63.90P/C13.44EPS next 5Y8.84%ROE25.33%52W High562.78 -22.48%Perf Year-20.63%
Cash/sh1.28P/FCF15.35EPS past 3/5Y-ROIC19.45%52W Low365.20 19.46%Perf 3Y-
Dividend Est.2.40 (0.55%)EV/EBITDA14.37Sales past 3/5Y5.82% 3.99%Gross Margin30.32%Volatility1.99% 1.97%Perf 5Y-
Dividend TTM2.40 (0.55%)EV/Sales2.36EPS Y/Y TTM8.65%Oper. Margin12.91%ATR (14)12.82Perf 10Y-
Dividend Ex-DateMay 28, 2026Quick Ratio0.83Sales Y/Y TTM4.52%Profit Margin10.23%RSI (14)55.22Recom2.56
Dividend Gr. 3/5Y14.13% 10.76%Current Ratio0.85EPS Q/Q0.36%SMA200.82%Beta0.18Target Price475.00
Payout12.53%Debt/Eq0.28Sales Q/Q1.70%SMA504.03%Rel Volume2.23Prev Close436.03
Employees15,695LT Debt/Eq0.11EarningsAug 04SMA2001.47%Avg Volume241.81KPrice436.27
IPO DateMay 03, 1973Option/ShortYes / YesEPS/Sales Surpr.6.60% 1.23%Net Debt/EBITDA0.53Volume540,136Change0.06%
Analyst Ratings
DateActionAnalystRatingTarget
Feb-27-26DowngradeRBC CapitalOutperform → Sector Perform
Jan-22-26DowngradeJefferiesBuy → Hold$550 → $475
Sep-02-25UpgradeJefferiesHold → Buy$550
Nov-05-24ReiteratedRBC CapitalOutperform$697 → $633
May-21-24ReiteratedRBC CapitalOutperform$592 → $697
Apr-28-22ReiteratedRBC CapitalOutperform$592
Mar-11-20UpgradeRBC CapitalSector Perform → Outperform
Nov-01-19UpgradeJMP SecuritiesMarket Perform → Market Outperform
Jul-19-13DowngradeCL KingBuy → Neutral
Oct-31-12DowngradeCL KingStrong Buy → Buy
Latest News
Jun-18-26
Jun-18-2601:41PM
1 Cash-Producing Stock Worth Your Attention and 2 Facing HeadwindsYahoo
Jun-15-26
Jun-15-2604:08PM
Chemed (CHE) Stock Valuation Check After Recent Mixed Performance And Undervaluation DebateYahoo
Jun-12-26
Jun-12-2606:45PM
Dividend Champion, Contender, And Challenger Highlights: Week Of June 14SeekingAlpha
Jun-10-26
Jun-10-2603:40PM
AVAH or CHE: Which Is the Better Value Stock Right Now?Yahoo
11:37AM
1 Profitable Stock for Long-Term Investors and 2 We AvoidYahoo
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2,5412,5302,431
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A1,7701,7721,577
Gross Profit771758854
Selling, General and Administrative Excl. Other425417424
Research and Development
000
Other Operating Expense18064
Operating Income329338366
Interest Expense422
Unusual Expense
———
Non-Operating Income (Expense)-24-19-35
Net Income Before Taxes349356399
Income Taxes909197
Consolidated Net Income259265302
Net Income From Continuing Operations259265302
Net Income259265302
EPS (Recurring)18.3918.4220.10
EPS (Basic, Before Extraordinaries)18.3918.4220.10
EPS (Diluted)18.3618.4219.89
EBITDA418422464
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio23.7623.23—
Price To Sales Ratio2.402.37—
Gross Margin30.3429.9635.13
Operating Margin12.9513.3615.06
Net Margin10.1910.4712.42
Shares Outstanding141415
Market Capitalization6,1085,990—
Operating Lease Expense
———
Insider Trading Volume
$486.48$461.85$437.21$412.57$387.94● Close Price0.00M1.27M2.54M3.81M5.08MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
LINDELL ANDREA RDirectorJun 09 '26Sale447.331,347602,5544,578Jun 10 12:00 AM
WALSH GEORGE J IIIDirectorMay 29 '26Sale437.83500218,9153,209May 29 12:00 AM
GRACE PATRICK PDirectorMay 08 '26Sale425.786025,5473,337May 08 12:00 AM
MCNAMARA KEVIN Jpresident and CEOMay 01 '26Sale421.132,000842,26090,219May 04 12:00 AM
MCNAMARA KEVIN Jpresident and CEOMar 27 '26Sale369.371,500554,05592,219Mar 30 12:00 AM
MCNAMARA KEVIN Jpresident and CEOMar 12 '26Sale403.182,000806,36093,719Mar 13 12:00 AM
LEE SPENCER Sexecutive vice presidentFeb 13 '26Option Exercise0.00804015,066Feb 17 12:00 AM
Witzeman Michael DVP & Chief Financial OfficerFeb 13 '26Option Exercise0.0066606,073Feb 17 12:00 AM
MCNAMARA KEVIN Jpresident and CEOFeb 13 '26Option Exercise0.004,374096,911Feb 17 12:00 AM
Judkins Brian CVP and Chief Legal OfficerFeb 13 '26Option Exercise0.0056602,538Feb 17 12:00 AM
HUTTON THOMAS Cvice presidentFeb 13 '26Option Exercise0.00320032,553Feb 17 12:00 AM
Wherley Joel LCEO - Vitas HealthcareFeb 13 '26Option Exercise0.0044001,290Feb 17 12:00 AM
MCNAMARA KEVIN Jpresident and CEONov 24 '25Sale437.552,000875,10094,197Nov 25 12:00 AM
MCNAMARA KEVIN Jpresident and CEOSep 26 '25Sale461.283,0001,383,84096,197Sep 29 12:00 AM
GRACE PATRICK PDirectorSep 09 '25Sale463.3915069,5093,397Sep 10 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR